Medical Condition News

RSS

Researchers reveal that reduction in mitochondrial DNA may lead to metastasis of breast cancer cells

For years, scientists have observed that tumor cells from certain breast cancer patients with aggressive forms of the disease contained low levels of mitochondrial DNA. But, until recently, no one was able to explain how this characteristic influenced disease progression.

11 Nov 2013

Findings demonstrate potential new therapeutic approach to treat fibrotic diseases

A team of scientists that includes Saint Louis University researchers has identified a new way to intervene in the molecular and cellular cascade that causes fibrosis - a condition where the body's natural process of forming scars for wound healing goes into overdrive and causes diseases.

11 Nov 2013

Studies highlight potential negative effects of soft drinks, sugar on kidney health

Two new studies highlight the potential negative effects that soft drinks and sugar can have on kidney health. Results of these studies will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA.

11 Nov 2013

Drug used to treat intestinal worms could protect people from periodontitis, says study

A drug currently used to treat intestinal worms could protect people from periodontitis, an advanced gum disease, which untreated can erode the structures-including bone-that hold the teeth in the jaw. The research was published ahead of print in Antimicrobial Agents and Chemotherapy.

11 Nov 2013

TGen-led study reveals viable target to prevent spread of brain cancer

A cellular pathway interaction known as TWEAK-Fn14, often associated with repair of acute injuries, also is a viable target for drug therapy that could prevent the spread of cancer, especially brain cancer, according to a study led by the Translational Genomics Research Institute.

11 Nov 2013

Researchers identify novel therapeutic approach for most frequent genetic cause of ALS

A team of scientists led by researchers from the University of California, San Diego School of Medicine and Ludwig Institute for Cancer Research have identified a novel therapeutic approach for the most frequent genetic cause of ALS, a disorder of the regions of the brain and spinal cord that control voluntary muscle movement, and frontal temporal degeneration, the second most frequent dementia.

10 Nov 2013

A*STAR scientists discover potential target to weed out progression of cancer

Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action.

10 Nov 2013

Scientists receive $1.2M grants to explore development of AD in individuals with Down syndrome

Donna Wilcock of the University of Kentucky Sanders-Brown Center on Aging is the lead investigator on a recently-funded project exploring the links between Alzheimer's disease and Down Syndrome. Elizabeth Head, also of Sanders-Brown Center on Aging, is a co-investigator on the project.

10 Nov 2013

Adequate vitamin D levels vital for maintaining the health of kidney transplant recipients

Adequate vitamin D levels are important for maintaining kidney transplant recipients' health, according to a study that will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA.

10 Nov 2013

Coding variants in immune disease-related genes play only small part in risk for psoriasis

Coding variants in immune disease-related genes play only a small part in the overall genetic risk for psoriasis, according to a new study led by Anhui Medical University and BGI.

10 Nov 2013

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

Scientists are gaining a new level of understanding of multiple sclerosis that may lead to new treatments and approaches to controlling the chronic disease, according to new research released today at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

10 Nov 2013

Lifestyle changes in diet and exercise show promise for learning, depression in teens

New studies released today underscore the potential impact of healthy lifestyle choices in treating depression, the effects of aging, and learning. The research focused on the effects of mind/body awareness, exercise, and diet, and was presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

10 Nov 2013

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease in adults and adolescents (ages 12 and up).

10 Nov 2013

Scientist shows how immune system 'attacks' liver cells during hepatitis by using JunB gene

Viral infections are the primary cause of liver inflammation or hepatitis, affecting hundreds of millions of people all over the world, and they represent a public health problem worldwide.

10 Nov 2013

Aptiom receives FDA approval to treat seizures associated with epilepsy

The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.

10 Nov 2013

Cancer detection programme using PENTAX Medical equipment achieves remarkable results

PENTAX Medical equipment has been used to set up a pioneering head and neck cancer detection programme at a hospital Trust in Coventry, which has achieved remarkable results; reduced the length of time the patient stays in hospital and reduced costs.

From PENTAX Medical Company 8 Nov 2013

Patrys gets second US patent for anti-cancer product PAT-LM1

Patrys Limited, a clinical stage biotechnology company is pleased to advise that it has been granted a second US patent for lead anti-cancer product PAT-LM1.

8 Nov 2013

Volition’s NuQ-5mc assay detects 75% of patients with colorectal cancer

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announces the publication of preliminary data from an ongoing independent trial of one of its NuQ assays.

8 Nov 2013

Peptide from cow's milk exhibits potent anticancer capability against human stomach cancer cell cultures

New research from a team of researchers in Taiwan indicates that a peptide fragment derived from cow's milk, known as lactoferricin B25 (LFcinB25), exhibited potent anticancer capability against human stomach cancer cell cultures.

8 Nov 2013

New zebrafish technique finds potential treatments for multiple diseases

Skeletal muscle has proved to be very difficult to grow in patients with muscular dystrophy and other disorders that degrade and weaken muscle. Researchers at Boston Children's Hospital's Stem Cell Program now report boosting muscle mass and reversing disease in a mouse model of Duchenne muscular dystrophy, using a "cocktail" of three compounds identified through a new rapid culture system. Adding the same compounds to stem cells derived from patients' skin cells, they then successfully grew human muscle cells in a dish.

8 Nov 2013

Medical Condition News

Researchers reveal that reduction in mitochondrial DNA may lead to metastasis of breast cancer cells

Findings demonstrate potential new therapeutic approach to treat fibrotic diseases

Studies highlight potential negative effects of soft drinks, sugar on kidney health

Drug used to treat intestinal worms could protect people from periodontitis, says study

TGen-led study reveals viable target to prevent spread of brain cancer

Researchers identify novel therapeutic approach for most frequent genetic cause of ALS

A*STAR scientists discover potential target to weed out progression of cancer

Scientists receive $1.2M grants to explore development of AD in individuals with Down syndrome

Adequate vitamin D levels vital for maintaining the health of kidney transplant recipients

Coding variants in immune disease-related genes play only small part in risk for psoriasis

Research findings may lead to new treatments, approaches for controlling multiple sclerosis

Lifestyle changes in diet and exercise show promise for learning, depression in teens

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

Scientist shows how immune system 'attacks' liver cells during hepatitis by using JunB gene

Aptiom receives FDA approval to treat seizures associated with epilepsy

Cancer detection programme using PENTAX Medical equipment achieves remarkable results

Patrys gets second US patent for anti-cancer product PAT-LM1

Volition’s NuQ-5mc assay detects 75% of patients with colorectal cancer

Peptide from cow's milk exhibits potent anticancer capability against human stomach cancer cell cultures

New zebrafish technique finds potential treatments for multiple diseases

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News